Latest news
Loading news…
Chroma Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Oxton, York, United Kingdom Founded 2000 51-100 employees For Profit
Chroma Therapeutics is focused on the R&D of novel small molecule drugs based on chromatin biology and cell accumulation.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
5
Patents
30
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 1
- Patents granted
- 30
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $4M
Company Info
- Founded
- 2000
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 5
- HQ
- Oxton, York, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 1.5
- Trend (30d)
- 1.6
- Trend (90d)
- 3.3
5
professional contacts at Chroma Therapeutics
Contact execs at Chroma Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Chroma Therapeutics
Loading news…
FAQs about Chroma Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.